1078
C. Eriksson et al. / Tetrahedron: Asymmetry 17 (2006) 1074–1080
1454, 1376, 1234, 1051, 699 (this peak and the absence of a
3.2.5. (S)-5-(1,3-Dioxolan-2-yl)-N-hydroxypentan-2-amine
10. Hydroxylamine benzoate 9 (0.57 g, 2.04 mmol) was
dissolved in THF–MeOH (6.2 ml, 1:1 v/v) and LiOH
(2 M, aq, 6.2 ml) was added dropwise. The mixture was
stirred for 2 h at room temperature. Et2O (25 ml) was
added and the phases were separated. The aqueous phase
was extracted with Et2O (3 · 25 ml) and the combined
organic phases were dried over MgSO4, filtered and concen-
trated in vacuo to yield hydroxylamine 10 (0.34 g, 95%). IR
[mmax(neat)/cmꢀ1]: 3281, 3056, 2917, 2849, 1662, 1368,
1140, 736. ½aꢂD ¼ ꢀ5:0 (c 0.12, CHCl3). H NMR d 1.10
(3H, d, J = 6.4 Hz), 1.30–1.55 (3H, m), 1.59–1.71 (3H,
m), 3.00 (1H, m), 3.800–4.01 (4H, m), 4.86 (1H, t,
J = 4.7 Hz), 5.84 (2H, br). 13C NMR d 17.5, 20.4,
33.4, 33.9, 57.2, 64.9 (2C), 104.4. Anal. Calcd for
C9H17NO: C, 54.8; H, 9.8; N, 8.0. Found: C, 54.9; H,
9.8; N, 7.8.
strong one at 970–960 cmꢀ1 indicate a cis-double bond).
20
1
½aꢂD ¼ þ50:3 (c 0.61, CHCl3). H NMR d 1.22 (3H, d,
J = 6.6 Hz), 2.54 (2H, m), 3.82 (2H, m), 3.94 (2H, m),
4.50 (1H, m), 4.91 (2H, m), 5.08 (2H, s), 5.41 (1H, dd
(app t), J = 9.0, 10.4 Hz), 5.51 (1H, m), 7.30 (5H, m). 13C
NMR d 21.7, 32.5, 44.6, 64.9, 65.0, 66.5, 103.5, 124.5,
128.02, 128.04 (2C), 128.5 (2C), 134.5, 136.6, 155.5.
Starting from (R)-benzyl-(1-methyl-2-oxoethyl)carbamate
ent-5, the (R)-enantiomer ent-7 was prepared using the
20
1
same procedure. The purity was 87% according to GC.
20
½aꢂD ¼ ꢀ45:1 (c 0.73, CHCl3). The NMR spectral data
were identical to those of 7.
3.2.3. (S)-5-(1,3-Dioxolan-2-yl)pentan-2-amine 8. Com-
pound 7 (2.32 g, 7.97 mmol) was dissolved in EtOH/EtOAc
(1:2, v/v, 41 ml), 10% palladium on charcoal (0.3 g) was
added and the mixture was hydrogenated at room temper-
ature and ambient pressure overnight. Filtration through a
pad of Celite and concentration in vacuo yielded free amine
8 (1.26 g, 99.3%, 98.5% purity according to GC) as a pale
yellow oil. IR [mmax(neat)/cmꢀ1]: 3286, 2953, 2873, 1617,
Starting from (R)-N-(benzoyloxy)-5-(1,3-dioxolan-2-yl)-
pentan-2-amine ent-9, the (R)-enantiomer ent-10 was
20
prepared using the same procedure. ½aꢂD ¼ þ5:0 (c 0.12,
CHCl3). The NMR spectral data were identical to those
of 10.
20
1
1461, 1378, 1142. ½aꢂD ¼ þ1:9 (c 0.78, CHCl3). H NMR
d 1.09 (3H, d, J = 6.3 Hz), 1.37–1.54 (4H, m), 1.64–1.71
(2H, m), 1.97 (2H, m), 2.92 (1H, m), 3.82–3.98 (4H, m),
4.86 (1H, t, J = 4.8 Hz). 13C NMR d 20.8, 23.4, 33.8,
39.5, 46.9, 64.9 (2C), 104.4.
3.2.6. (S)-2-Methyl-2,3,4,5-tetrahydropyridine 1-oxide 3.
To hydroxylamine 10 (1 g, 5.71 mmol) was added 2 M
HCl (aq, 10 ml). The solution was stirred at room temper-
ature for 25 min after which water (30 ml) was added and
the pH adjusted to ꢁ11 with Na2CO3. The reaction mix-
ture was extracted with Et2O (2 · 50 ml) and CHCl3
(5 · 50 ml). The combined CHCl3 phases were filtered
through MgSO4 and the filtrate evaporated to give nitrone
3 (yellow oil), which was used immediately in the next step.
Starting from (R)-benzyl-[(2Z)-4-(1,3-dioxolan-2-yl)-1-
methylbut-2-en-1- yl]carbamate (ent-7), the (R)-enantiomer
ent-8 was prepared by the same procedure. The purity was
20
97.9% according to GC. ½aꢂD ¼ ꢀ1:3 (c 0.79, CHCl3). The
NMR spectral data were identical to those of 8.
In the same way, enantiomer ent-3 was prepared, starting
from hydroxylamine ent-10, and used immediately in the
next step.
3.2.4.
(S)-N-(Benzoyloxy)-5-(1,3-dioxolan-2-yl)pentan-2-
amine 9. Amine 8 (0.58 g, 3.64 mmol) was dissolved in
an aqueous buffer [pH 10.5, 18.2 ml, prepared from
NaHCO3 (0.75 M, aq) and NaOH (1.5 M, aq)].11 Benzoyl
peroxide (25% w/w in H2O, 2.35 g, 7.28 mmol) dissolved
in CH2Cl2 (18.2 ml) was added dropwise at ambient tem-
perature and the resulting mixture stirred vigorously for
24 h. The phases were separated and the aqueous phase
was extracted with CH2Cl2 (2 · 30 ml). The combined
organic layers were dried over Na2SO4, filtered and the
solvent was evaporated off. The crude product was purified
by chromatography on silica gel (EtOAc in cyclohexane,
3.2.7. (2S,6S)-2-Allyl-6-methylpiperidin-1-ol 15. To allyl
boronic ester 14 (1.15 g, 6.85 mmol) at ꢀ78 ꢁC, nitrone 3
(5.71 mmol) in CH2Cl2 (20 ml) was added. Dimethylzinc
(2.0 M in toluene, 5.71 ml, 11.4 mmol) was added slowly
after which the mixture was allowed to reach room temper-
ature and stirred overnight. The mixture was cooled in an
ice bath and water (5 ml) was added slowly. The mixture
was filtered through a pad of Celite and the filtrate evapo-
rated. The crude product was purified by MPLC on
silica gel (EtOAc–c-hexane, 0%!100%) yielding 2-(S)-
1%!25%) yielding product 9 (0.57 g, 56.1%). IR [mmax
-
(neat)/cmꢀ1]: 3236, 3063, 2950, 2878, 1718, 1451, 1271,
20
1
733, 710. ½aꢂD ¼ ꢀ1:5 (c 0.4, CH2Cl2). H NMR d 1.20
(3H, d, J = 6.4 Hz), 1.44–1.61 (3H, m), 1.70 (3H, m),
3.23 (1H, m), 3.84 (2H, m), 3.95 (2H, m), 4.85 (1H, m),
7.46 (2H, m), 7.58 (1H, m), 8.02 (2H, m). 13C NMR d
17.9, 20.4, 24.0, 33.82, 33.84, 56.7, 64.8, 64.9, 104.3,
104.5, 128.46, 128.51, 129.3, 133.3, 166.8. Calcd for
C15H21NO4: C, 64.5; H, 7.6; N, 5.0. Found: C, 64.2; H,
7.9; N, 4.6.
allyl-6-(S)-methylpiperidin-1-ol 15 (0.3 g, 33.8%). IR [mmax-
20
(neat)/cmꢀ1]: 3375, 3077, 2935, 2862, 996, 919. ½aꢂD ¼ ꢀ7:8
(c 0.32, CHCl3). 1H NMR d 1.10 (3H, d, J = 6.4 Hz), 1.21–
1.35 (3H, m), 1.55–1.85 (3H, m), 2.17 (1H, m), 2.47 (2H,
m), 2.69 (1H, m), 4.95–5.10 (3H, m), 5.84 (1H, m). 13C
NMR d 20.5, 23.7, 31.2, 34.2, 38.6, 63.3, 67.0, 116.4,
136.1. Anal. Calcd For C9H17NO: C, 69.6; H, 11.0; N,
9.0. Found: C, 69.4; H, 10.9; N, 8.8.
1
Starting from (R)-5-(1,3-dioxolan-2-yl)pentan-2-amine ent-
trans-Isomer 16 (0.15 g, 17.0%): H NMR d 5.78 (1H, m),
8, the (R)-enantiomer ent-9 was prepared by the same pro-
5.05 (2H, m), 3.30 (1H, m), 2.98 (1H, m), 2.68 (1H, m),
2.20 (1H, m), 1.30–1.95 (5H, m), 1.20 (1H, m), 1.15 (3H,
d, J = 5.7 Hz).
20
cedure. ½aꢂD ¼ þ1:5 (c 0.4, CH2Cl2). The NMR spectral
data were identical to those of 9.